The globalblood transfusion diagnostics marketsize is expected to reach USD 5.9 Billion by 2027 according to a new study by Polaris Market Research. The report “Blood Transfusion Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Kits, and Others); By Application (Blood Grouping, and Disease Screening {Serological, and Molecular Disease Screening}); By End Use (Hospitals, Blood Banks, Diagnostic Laboratories, and Others); By Regions; Segment Forecast, 2020 – 2027”gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global market is anticipated to witness growth owing to the surge in donations and consequently blood screening procedures, organ transplantation compatibility tests, and technological advancements in the transfusion diagnostics. Moreover, government sponsored screening, advent of rapid tests, and change in consumer perception also boosting the sale of blood diagnostics products and services.
The market is fragmented based on product, application, end-use, and region. In terms of product, the market is segmented into instruments, reagents & kits, and others. Based on application, the market is bifurcated into grouping and disease screening. The end use segment is further divided into hospitals, blood banks, diagnostic laboratories, and others.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link://m.jiayuancx.com/industry-analysis/global-blood-transfusion-diagnostics-market/request-for-sample
Segment Highlight
- The players including Grifols S.A., Abbott Laboratories; Bio-Rad Laboratories, Inc. together held a significant market share in the market over the past couple of years
- Reagents & kits accounted for the largest revenue share in 2019 owing to the increasing demand for the products to screen patient & donor samples and availability of wide variety of kits for blood typing and grouping
- North America dominated the global market, holding almost one-third of the market share throughout forecast period. Consumer perception towards the benefits of plasma screening procedures, presence of key players in the marketplace, and robust healthcare infrastructure to carry out organ transplantation surgeries are driving the market growth
- Based on application, the disease screening segment is projected to constitute around 50% of the market by the end of 2027. The segment’s high share can be attributed to compulsory blood compatibility tests in different surgeries
List of Key Players
- Grifols S.A.
- Immucor Inc.
- Ortho Clinical Diagnostics
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd
- Quotient Ltd
- Others
Polaris Market Research has segmented theblood transfusion diagnostics market report on the basis of product, application, enduse and region
Blood Transfusion Diagnostics, Product Outlook (Revenue – USD Million, 2016 – 2027)
- Instruments
- Reagents & Kits
- Others
Blood Transfusion Diagnostics, Application Outlook(Revenue – USD Million, 2016 – 2027)
- Blood Grouping
- Disease Screening
- Serological
- 米olecular Disease Screening
Blood Transfusion Diagnostics, End Use Outlook (Revenue – USD Million, 2016 – 2027)
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Others
Blood Transfusion Diagnostics Regional Outlook (Revenue – USD Million, 2016 – 2027)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Netherlands
- Austria
- Asia Pacific
- China
- India
- Japan
- 米alaysia
- South Korea
- Indonesia
- Central & South America
- 米exico
- Brazil
- Argentina
- 米iddle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa